NATIONAL REPORTS -- The cost of consumer-driven health plans (CDHPs) grew at a significantly slower rate in 2005 than other types of plans, U.S. employers reported in a recent survey.
NATIONAL REPORTS-The cost of consumer-driven health plans (CDHPs) grew at a significantly slower rate in 2005 than other types of plans, U.S. employers reported in a recent survey.
"Controlling rising health benefit cost continues to be the number one influencer of employer strategies, according to industry experts. Unfortunately, incremental changes focused on shifting costs-either through plan design, contributions, or a combination of both-have not had a significant enough impact to satisfy purchasers," says Barbara P. Gniewek, principal and healthcare industry leader of Deloitte's Human Capital practice. "Employers feel transformational change is required to slow and/or stop the rising cost trends."
A survey by the Deloitte Center for Health Solutions and cosponsored by The ERISA Industry Committee, found that while most employers still offer several platform types, enrollment in POS, PPO and HMO plans has dropped slightly, and more employees are selecting consumer-directed options. "CDHP rate increases are much lower [2.6% in 2006] than traditional options [7.5%], and therefore, we expect CDHP enrollment to continue to grow," Gniewek tells MANAGED HEALTHCARE EXECUTIVE.
"This often includes some level of consumerism, account-based plans, preventive and wellness incentives and care/disease management programs," Gniewek says. "Risk stratification and data integration are going to be ways to measure the impact of these new plan types."
In addition to cost savings, CDHPs offer employees an additional tool to save money tax-free for retiree health, says Edwina Rogers, vice president health policy for The ERISA Industry Committee. "Further, many of our members are aggressively working to supply their employees with quality and efficiency information on healthcare providers and electronic medical records so they can make wise choices with their healthcare dollars," Rogers says.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Sexual Health and HIV Care Integration Key to Better Care | IAS 2025
July 14th 2025Integrating HIV and sexual health care is essential for improving outcomes, but global stigma, funding cuts—especially the defunding of USAID—and structural barriers like limited access and political resistance continue to hinder progress, experts emphasized at IAS 2025.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Expands Kerendia’s Use to Treat Common Form of Heart Failure
July 14th 2025Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic kidney disease (CKD) associated with type 2 diabetes. This new approval extends its use to a broader patient population.
Read More
Black Women Can Successfully Be Started on Long-Acting Apretude for HIV PrEP | IAS 2025
July 14th 2025Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in various clinics but also providing more flexible scheduling and partnering with specialty pharmacies.
Read More